Adeka (4401) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Oct, 2026Executive summary
FY2023 net sales dipped slightly YoY, while operating and current profit reached record highs; profit attributable to owners of parent also rose.
ADX 2026 sets FY2026 targets of JPY 500 billion net sales and JPY 53 billion operating profit, with growth investment focused on electronics and IT materials.
Financial highlights
FY2023 net sales JPY 399.7 billion, down JPY 3.5 billion YoY; operating profit JPY 35.4 billion, up JPY 3 billion; current profit JPY 35.7 billion, up JPY 3.1 billion.
Profit attributable to owners of parent JPY 22.9 billion, up JPY 6.1 billion YoY; EPS JPY 224.9, up JPY 61.6.
Operating profit benefited from JPY 7.2 billion in net pricing and JPY 2.7 billion from FX; fixed and manufacturing costs reduced profit by JPY 4.2 billion, and lower volume by JPY 2.6 billion.
Outlook and guidance
FY2024 forecast: net sales JPY 425 billion, up JPY 25.2 billion YoY; operating profit JPY 37.3 billion, up JPY 1.8 billion; current profit JPY 36.4 billion, up JPY 0.6 billion.
FY2024 profit attributable to owners of parent forecast at JPY 23 billion, virtually unchanged YoY; EPS JPY 225.2 and dividend JPY 90 per share.
ADX 2026 FY2026 targets: net sales JPY 500 billion, operating profit JPY 53 billion, ROE 11%, ROIC 10.5%, and CapEx JPY 75 billion.
FY2024–FY2026 plan targets dividend payout ratio of at least 40%; segment sales and operating profit are expected to grow broadly, with food products the exception.
Latest events from Adeka
- Q1 earnings fell on volume weakness; FY profit targets stayed intact.document-source184401
Q1 2024 - Pricing and FX cushioned volume-led pressure as FY2023 guidance remained unchanged.4401
Q3 2024 - Strong sales and profit growth led by chemicals and semiconductors; outlook and dividends raised.4401
Q1 2027 - Record FY2025 results; FY2026 forecasts further growth but exclude Middle East impacts.4401
Q4 2026 - H1 growth lifted FY2024 guidance and dividends, led by Chemicals.4401
Q2 2025 - Nine-month profit rose 25.1%, led by Chemicals, as semiconductor investment advanced.4401
Q3 2025 - Record FY2024 results, with FY2025 growth forecast amid tariff and cost risks.4401
Q4 2025 - Profit and sales rose, led by Life Science, with stable outlook and higher dividend forecast.4401
Q1 2026 - Profit rose on strong Life Science and Environmental Materials, offsetting Chemicals weakness.4401
Q3 2026